RECOMMENDATIONS FOR METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS ( MASH) DISEASE MANAGEMENT: A MODIFIED DELPHI PANEL

被引：0
|
作者：
Watzker, Anna [1 ]
Delegge, Mark [2 ]
Fernandes, Gail [1 ]
Melaragno, Matthew [1 ]
Williams, Rhys [2 ]
Godinho, Fatima [2 ]
Drymaliti, Kyriaki [2 ]
Engel, Samuel [1 ]
机构：
[1] Merck & Co Inc, Rahway, NJ USA
[2] IQVIA, Durham, NC USA
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1730
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Nanoformulations for the diagnosis and treatment of metabolic dysfunction-associated steatohepatitis
    Qin, Xueying
    Liu, Jingjing
    ACTA BIOMATERIALIA, 2024, 184 : 37 - 53
  • [42] The clinical and economic burdens of metabolic dysfunction-associated steatohepatitis
    Charlton, Michael
    Tonnu-Mihara, Ivy
    Teng, Chia-Chen
    Zhou, Ziqi
    Asefaha, Feven
    Luthra, Rakesh
    Hoovler, Anthony
    Uzoigwe, Chioma
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 919 - 930
  • [43] Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis
    Devasia, Arun George
    Ramasamy, Adaikalavan
    Leo, Chen Huei
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (04)
  • [44] Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis
    Loomba, Rohit
    Hartman, Mark L.
    Lawitz, Eric J.
    Vuppalanchi, Raj
    Boursier, Jerome
    Bugianesi, Elisabetta
    Yoneda, Masato
    Behling, Cynthia
    Cummings, Oscar W.
    Tang, Yuanyuan
    Brouwers, Bram
    Robins, Deborah A.
    Nikooie, Amir
    Bunck, Mathijs C.
    Haupt, Axel
    Sanyal, Arun J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (04): : 299 - 310
  • [45] Noninvasive testing in the diagnosis of metabolic dysfunction-associated steatohepatitis
    Marks, Lucas M.
    Jensen, Thomas
    DeGrado, Timothy R.
    METABOLISM AND TARGET ORGAN DAMAGE, 2024, 4 (03):
  • [46] Identification of biomarkers for the diagnosis in colorectal polyps and metabolic dysfunction-associated steatohepatitis (MASH) by bioinformatics analysis and machine learning
    Geng, Ying
    Li, Yifang
    Liu, Ge
    Jiao, Jian
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [47] New advances in novel pharmacotherapeutic candidates for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) between 2022 and 2024
    Wong, Shu Wei
    Yang, Yong-yu
    Chen, Hui
    Xie, Li
    Shen, Xi-zhong
    Zhang, Ning-ping
    Wu, Jian
    ACTA PHARMACOLOGICA SINICA, 2025,
  • [48] Environmental toxicants modulate disease severity in pediatric metabolic dysfunction-associated steatohepatitis
    Jain, Ajay K.
    Busgang, Stefanie A.
    Gennings, Chris
    Yates, Katherine P.
    Schwimmer, Jeffrey B.
    Rosenthal, Philip
    Murray, Karen F.
    Molleston, Jean P.
    Scheimann, Ann
    Xanthakos, Stavra A.
    Behling, Cynthia A.
    Carpenter, Danielle
    Fishbein, Mark
    Neuschwander-Tetri, Brent A.
    Tonasia, James
    Vos, Miriam B.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2024, 79 (05): : 943 - 953
  • [49] Non-invasive assessment of liver inflammation in metabolic dysfunction-associated steatohepatitis (MASH) using MRI cytometry
    Jiang, Xiaoyu
    Izzy, Manhal
    Washington, Kay
    Gore, John
    Xu, Junzhong
    JOURNAL OF HEPATOLOGY, 2024, 80 : S595 - S595
  • [50] METABOLISM AND THERAPEUTIC EFFECTS OF N-ACYL AMINO ACIDS IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) AND ATHEROSCLEROSIS
    Anand, Sumit Kumar
    Das, Sandeep
    Lee, Jennifer
    Richard, Koral
    McKinney, Peyton
    Rohilla, Sumati
    Pandey, Nilesh
    Kumar, Dhananjay
    Pearson-Gallion, Brenna
    Wang, Lu
    Finney, Alexandra
    Zhang, Jifeng
    Sun, Duxin
    Liu, Wanqing
    Chen, Eugene
    Orr, Wayne
    Dhanesha, Nirav
    Yurdagul, Arif
    Rom, Oren
    HEPATOLOGY, 2024, 80
12345